Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Study of Imatinib Therapeutic Drug Monitoring in Gastrointestinal Stromal Tumor
Brief Summary: Imatinib can lead to long recurrence free survival in patients diagnosed with gastrointestinal stromal tumors (GIST); however side effects can significantly hinder quality of life for our patients.
This study will use therapeutic drug monitoring to improve quality of life and symptoms and assess how many patients maintain therapeutic levels.
Free drug levels and pharmokinetics of imatinib will also be monitored.